Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Pregabalin	254
Overall Study	STARTED	Levetiracetam	255
Overall Study	Completed Titration Phase	Pregabalin	226
Overall Study	Completed Titration Phase	Levetiracetam	236
Overall Study	Completed Maintenance Phase	Pregabalin	208
Overall Study	Completed Maintenance Phase	Levetiracetam	210
Overall Study	Entered Opt Blinded Continuation Phase	Pregabalin	185
Overall Study	Entered Opt Blinded Continuation Phase	Levetiracetam	195
Overall Study	COMPLETED	Pregabalin	80
Overall Study	COMPLETED	Levetiracetam	82
Overall Study	NOT COMPLETED	Pregabalin	174
Overall Study	NOT COMPLETED	Levetiracetam	173

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00537238/flow